With cardiovascular disease (CVD) causing 26% of all deaths and costing the UK healthcare system over £8 billion a year, it is felt more can be done to prevent many thousands of avoidable deaths and ill health. As well as highlighting some of PHE’s programmes and resources, the plan includes some CVD initiatives planned for 2017 /18.
This includes work looking at a new return on investment tool, air pollution, sugar reduction and the NHS Health Check programmes. The plan is aimed at those involved in the commissioning and provision of services for CVD and its prevention such as clinicians, local authorities, service commissioners, public health specialists, the third sector and PHE staff.
NHS launches new drive to save thousands of people from heart attacks and strokes | Public Health England
New analysis from Public Health England suggests that there is now an opportunity to prevent more than 9,000 heart attacks and at least 14,000 strokes over the next 3 years with better detection and management of:
high blood pressure
atrial fibrillation (AF)
Around 5.5 million people in England have undiagnosed high blood pressure and nearly half a million have undiagnosed AF, which are both usually symptomless conditions that substantially increase the risk of stroke, heart attack, dementia and limb amputations.
The new analysis shows the scale of the prevention opportunity across England over 3 years if treatment of these high-risk conditions is optimised. Achieving optimal treatment in all people with diagnosed high blood pressure has the potential to avert up to 9,710 heart attacks and 14,500 strokes, saving up to £274 million. Achieving optimal treatment for those diagnosed with AF has the potential to avert up to 14,220 strokes, saving £241 million.
Data and analysis of cardiovascular disease (CVD) prevalence, variation, treatment and outcomes in clinical commissioning groups (CCG) areas | Public Health England
Healthcare professionals can use this resource to check the prevalence, variation and treatment of cardiovascular conditions in the local area. This can help with planning, commissioning and improving local services.
The pack uses GP practice data on prevention, detection and management across a range of cardiovascular conditions:
high cardiovascular risk and hypertension
stroke and atrial fibrillation
coronary heart disease and heart failure
The pack has a chapter for each of these conditions with:
a narrative that explains the case for prevention and suggestions actions
data that show the variation between local practices and between demographically similar clinical commissioning group (CCG) areas
The data also identifies the number of undiagnosed and inadequately treated people in the local area.
It is uncertain whether multiple health behaviour change (MHBC) interventions are effective for the primary prevention of cardiovascular disease (CVD) in primary care | BMJ Open
Background: A systematic review and a meta-analysis were performed to evaluate the effectiveness of MHBC interventions on CVD risk and CVD risk factors; the study also evaluated associations of theoretical frameworks and intervention components with intervention effectiveness.
Conclusions: MHBC interventions delivered to CVD-free participants in primary care did not appear to have quantitatively important effects on CVD risk factors. Better reporting of interventions’ rationale, content and delivery is essential to understanding their effectiveness.
Report from The British Heart Foundation (BHF) suggests that large numbers of people in the UK are still failing to meet recommendations for physical activity, putting them at greater risk of heart and circulatory disease.
The British Heart Foundation has published Physical Inactivity Report 2017. This report provides an overview of the levels of physical inactivity and sedentary behaviour in adults across the UK.
The Government recommends that adults undertake at least 150 minutes of moderate intensity physical activity a week and strength activities on at least two days a week . It is also recommended that adults minimise their levels of sedentary behaviour.
The data in this report suggests that large numbers of people in the UK are failing to meet these recommendations for physical activity.
The statistics also show that levels of sedentary behaviour in the UK remain high. This is of particular concern as evidence is growing which shows that sedentary behaviour – time in which energy expenditure is very low – is an independent risk factor to physical inactivity.
The impact of physical inactivity and sedentary lifestyles also weighs heavily on UK healthcare, estimated to cost as much as £1.2 billion a year.
The report suggests that making physical activity easier and more accessible for all is of paramount importance if we are to reduce the burden of inactivity-related ill health and improve the future cardiovascular health of our population.
The Cochrane Database of Systematic Reviews has published ‘Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases’.
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and disability worldwide, yet ASCVD risk factor control and secondary prevention rates remain low. A fixed-dose combination of blood pressure- and cholesterol-lowering and antiplatelet treatments into a single pill, or polypill, has been proposed as one strategy to reduce the global burden of ASCVD.
This study aims to determine the effect of fixed-dose combination therapy on all-cause mortality, fatal and non-fatal ASCVD events, and adverse events. The researchers also sought to determine the effect of fixed-dose combination therapy on blood pressure, lipids, adherence, discontinuation rates, health-related quality of life, and costs.
The authors concluded that the effects of fixed-dose combination therapy on all-cause mortality or ASCVD events are uncertain. A limited number of trials reported these outcomes, and the included trials were primarily designed to observe changes in ASCVD risk factor levels rather than clinical events, which may partially explain the observed differences in risk factors that were not translated into differences in clinical outcomes among the included trials. Fixed-dose combination therapy is associated with modest increases in adverse events compared with placebo, active comparator, or usual care but may be associated with improved adherence to a multidrug regimen. Ongoing, longer-term trials of fixed-dose combination therapy will help demonstrate whether short-term changes in risk factors might be maintained and lead to expected differences in clinical events based on these changes.
Women from low socioeconomic backgrounds are 25% more likely to suffer a heart attack than disadvantaged men. | OnMedica |Journal of Epidemiology and Community Health.
In a review of 116 studies, researchers from The George Institute for Global Health examined data from 22 million people from North America, Europe, Asia and Australasia and found, as expected, that markers of a lower socioeconomic status (education, occupation, income or area of residence), compared to a higher, are associated with a higher risk of cardiovascular disease for both sexes. However, the results also showed women from more disadvantaged backgrounds were relatively more likely to suffer from coronary heart disease than men from similar backgrounds.